These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 8609412

  • 1. Induction of antitumor immunity using bone marrow-generated dendritic cells.
    Porgador A, Snyder D, Gilboa E.
    J Immunol; 1996 Apr 15; 156(8):2918-26. PubMed ID: 8609412
    [Abstract] [Full Text] [Related]

  • 2. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M, Heirman C, Van Meirvenne S, Devos S, Corthals J, Moser M, Thielemans K.
    J Immunol; 1999 Jan 01; 162(1):144-51. PubMed ID: 9886380
    [Abstract] [Full Text] [Related]

  • 3. Dendritic cells loaded with exogenous antigen by electroporation can enhance MHC class I-mediated antitumor immunity.
    Kim KW, Kim SH, Jang JH, Lee EY, Park SW, Um JH, Lee YJ, Lee CH, Yoon S, Seo SY, Jeong MH, Lee ST, Chung BS, Kang CD.
    Cancer Immunol Immunother; 2004 Apr 01; 53(4):315-22. PubMed ID: 14685778
    [Abstract] [Full Text] [Related]

  • 4. Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells.
    Sun JB, Eriksson K, Li BL, Lindblad M, Azem J, Holmgren J.
    Clin Immunol; 2004 Jul 01; 112(1):35-44. PubMed ID: 15207780
    [Abstract] [Full Text] [Related]

  • 5. Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity.
    Cao X, Zhang W, He L, Xie Z, Ma S, Tao Q, Yu Y, Hamada H, Wang J.
    J Immunol; 1998 Dec 01; 161(11):6238-44. PubMed ID: 9834111
    [Abstract] [Full Text] [Related]

  • 6. Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.
    Gabrilovich DI, Nadaf S, Corak J, Berzofsky JA, Carbone DP.
    Cell Immunol; 1996 May 25; 170(1):111-9. PubMed ID: 8665591
    [Abstract] [Full Text] [Related]

  • 7. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z, Ahmed KA, Hao S, Zhang X, Xie Y, Munegowda MA, Meng Q, Chibbar R, Xiang J.
    Autoimmunity; 2008 Nov 25; 41(7):501-11. PubMed ID: 18855194
    [Abstract] [Full Text] [Related]

  • 8. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J, Saffold S, Cao X, Krauss J, Chen W.
    J Immunol; 1998 Nov 15; 161(10):5516-24. PubMed ID: 9820528
    [Abstract] [Full Text] [Related]

  • 9. [Enhanced antitumor effects induced by lymphotactin gene-modified dendritic cells after pulsed with tumor antigen peptide].
    Zhang W, He L, Cao X.
    Zhonghua Yi Xue Za Zhi; 1999 Mar 15; 79(3):170-3. PubMed ID: 11601032
    [Abstract] [Full Text] [Related]

  • 10. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
    Xie Y, Zhang H, Li W, Deng Y, Munegowda MA, Chibbar R, Qureshi M, Xiang J.
    J Immunol; 2010 Nov 01; 185(9):5268-78. PubMed ID: 20881190
    [Abstract] [Full Text] [Related]

  • 11. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
    Strome SE, Voss S, Wilcox R, Wakefield TL, Tamada K, Flies D, Chapoval A, Lu J, Kasperbauer JL, Padley D, Vile R, Gastineau D, Wettstein P, Chen L.
    Cancer Res; 2002 Mar 15; 62(6):1884-9. PubMed ID: 11912169
    [Abstract] [Full Text] [Related]

  • 12. Coupling of antigen to cholera toxin for dendritic cell vaccination promotes the induction of MHC class I-restricted cytotoxic T cells and the rejection of a cognate antigen-expressing model tumor.
    Eriksson K, Sun JB, Nordström I, Fredriksson M, Lindblad M, Li BL, Holmgren J.
    Eur J Immunol; 2004 May 15; 34(5):1272-81. PubMed ID: 15114660
    [Abstract] [Full Text] [Related]

  • 13. Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides.
    Nair S, Wearsch PA, Mitchell DA, Wassenberg JJ, Gilboa E, Nicchitta CV.
    J Immunol; 1999 Jun 01; 162(11):6426-32. PubMed ID: 10352256
    [Abstract] [Full Text] [Related]

  • 14. Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes.
    Hao S, Bai O, Yuan J, Qureshi M, Xiang J.
    Cell Mol Immunol; 2006 Jun 01; 3(3):205-11. PubMed ID: 16893501
    [Abstract] [Full Text] [Related]

  • 15. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.
    Porgador A, Gilboa E.
    J Exp Med; 1995 Jul 01; 182(1):255-60. PubMed ID: 7540653
    [Abstract] [Full Text] [Related]

  • 16. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
    He T, Tang C, Xu S, Moyana T, Xiang J.
    Cell Mol Immunol; 2007 Apr 01; 4(2):105-11. PubMed ID: 17484804
    [Abstract] [Full Text] [Related]

  • 17. Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.
    Saha A, Chatterjee SK, Foon KA, Primus FJ, Bhattacharya-Chatterjee M.
    Cancer Res; 2003 Jun 01; 63(11):2844-54. PubMed ID: 12782590
    [Abstract] [Full Text] [Related]

  • 18. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo.
    Böhm W, Schirmbeck R, Elbe A, Melber K, Diminky D, Kraal G, van Rooijen N, Barenholz Y, Reimann J.
    J Immunol; 1995 Oct 01; 155(7):3313-21. PubMed ID: 7561024
    [Abstract] [Full Text] [Related]

  • 19. Augmented induction of CD8+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptide.
    Kikuchi T, Uehara S, Ariga H, Tokunaga T, Kariyone A, Tamura T, Takatsu K.
    Immunology; 2006 Jan 01; 117(1):47-58. PubMed ID: 16423040
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
    Maecker HT, Umetsu DT, DeKruyff RH, Levy S.
    J Immunol; 1998 Dec 15; 161(12):6532-6. PubMed ID: 9862678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.